Session 3: Genome Engineering and Therapeutics

When:

8:15 AM, Monday 12 Jun 2023 (2 hours)

Where:

Loyola campus - Concordia University - HU building - room 125 (ground floor)

Dr. Elena Kuzmin

Dr. Elena Kuzmin

Chair

Concordia University - Centre for Applied Synthetic Biology and Centre for Structural and Functional Genomics

Assistant Professor, Department of Biology

Sub Sessions

Anna Jezierski - Advancing induced pluripotent stem cell derived chimeric antigen receptor based natural killer cell therapy leveraging genome engineering approaches to advance off-the-shelf therapies
Speaker Anna Jezierski (National Research Council of Canada)
30 minutes | 8:15 AM - 8:45 AM Part of: Session 3: Genome Engineering and Therapeutics
Talk

Alejandro Álvarez Quilón - CRISPR and Base Editing Genetic Screens Enable the Discovery and Validation of Drug Targets for Precision Oncology
Speaker Alejandro Álvarez Quilón (Repare Therapeutics)
30 minutes | 8:45 AM - 9:15 AM Part of: Session 3: Genome Engineering and Therapeutics
Talk

Thierry Bertomeu - Large scale genome-wide CRISPR/Cas9 chemogenomic KO screens reveal drug mechanisms of action and identify novel gene functions
Speaker Thierry Bertomeu (Université de Montréal)
15 minutes | 9:15 AM - 9:30 AM Part of: Session 3: Genome Engineering and Therapeutics
Talk

4 Oral presentations selected from abstracts
45 minutes | 9:30 AM -10:15 AM Part of: Session 3: Genome Engineering and Therapeutics
Talk

Send feedback

Allow attendees to rate sessions with a "thumbs up" or "thumbs down".

Allow attendees to send feedback about sessions

Allows attendees to send short textual feedback to the organizer for a session. This is only sent to the organizer and not the speakers.

Display the list of attendees for each session.

To respect data privacy rules, this option only displays profiles of attendees who have chosen to share their profile information publicly.

Allow attendees to participate in a discussion thread for sessions

Changes here will affect all session detail pages